Fidelity Investments’s Mural Oncology MURA Stock Holding History

Fidelity Investments’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400	Closed	-$828	–	5529
2025 Q3	$828	Buy	400 +290	+264%	+$623	﹤0.01%	5040
2025 Q2	$271	Sell	110 -3,680	-97%	-$8.67K	﹤0.01%	5077
2025 Q1	$4.78K	Sell	3,790 -4,079	-52%	-$14.9K	﹤0.01%	4718
2024 Q4	$25.3K	Sell	7,869 -12,711	-62%	-$44.8K	﹤0.01%	4124
2024 Q3	$64.4K	Buy	20,580 +11,423	+125%	+$37.2K	﹤0.01%	3674
2024 Q2	$28.8K	Sell	9,157 -669	-7%	-$2.47K	﹤0.01%	3897
2024 Q1	$48K	Sell	9,826 -32,572	-77%	-$158K	﹤0.01%	3604
2023 Q4	$251K	Buy	+42,398	New	+$170K	﹤0.01%	2892

Fidelity Investments's MURA Position: Q4 2025 in Review

Fidelity Investments sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 400 shares — an estimated $828 sold.

Fidelity Investments first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $251K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Fidelity Investments reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Fidelity Investments sold 400 Mural Oncology shares in Q4 2025, an estimated $828.
Fidelity Investments first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Fidelity Investments's Mural Oncology position peaked at $251K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.